NorthRock Partners’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
NorthRock Partners's LH Position: Q2 2026 in Review
NorthRock Partners increased its Labcorp (LH) stake by 6.7% in Q2 2026, buying an estimated $34.7K and bringing the position to 2,099 shares worth $588K. The position accounts for 0.01% of the portfolio, ranked #406.
NorthRock Partners first reported a position in LH in Q2 2025 and has held it in 5 quarters since. The position peaked at $813K in Q3 2025. 1,059 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- NorthRock Partners held 2,099 shares of Labcorp worth $588K as of Q2 2026.
- NorthRock Partners bought 132 Labcorp shares in Q2 2026, an estimated $34.7K.
- Labcorp made up 0.01% of NorthRock Partners's portfolio in Q2 2026, its #406 holding.
- NorthRock Partners first reported a position in Labcorp in Q2 2025 and has held it in 5 quarters since.
- NorthRock Partners's Labcorp position peaked at $813K in Q3 2025.
- 1,059 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.